Friday , February 23 2018
Home / Therapies / Physical Activity (page 8)

Physical Activity

Physical Activity and Exercise for Diabetics: Diabetes in Control answers key questions about the uses and challenges of physical for diabetes management, including:
– How physical activity affects diabetes patients
– How/when a healthcare professional should or should not use exercise as a treatment for diabetic patients
– What does a healthcare professional needs to know to enhance the safety of physical activity for diabetes patients

Take Back Your Steps!

It has long been known that regular physical activity is essential for good health. Even well over 2,000 years ago, Hippocrates (460-370 BC) noted, “Eating alone will not keep man well; he must also take exercise. For food and exercise work together to produce health.” Why, then, is it so hard for us to embrace this concept of being active now?

Read More »

Losing Weight with Diabetes: What Prevents It and Causes Weight Gain

I recently was included in a discussion on a Facebook group for athletes with diabetes about how hard it can be to lose weight through exercise. While I would never claim to have all the answers on this topic, here are some ideas about what can make you gain weight or keep you from losing weight with diabetes, based on my decades of professional and personal experience with diabetes and weight management, and what you can do about it.

Read More »

Practical Diabetes Care, 3rd Ed., Excerpt #30: Hypertension Part 5 of 5

alt

David Levy, MD, FRCP Diuretics Thiazide diuretics have been the mainstay of antihypertensive treatment since the first potent thiazide was introduced in 1957, and have often been the agents against which other drug classes have been compared in important clinical trials [18]. They are especially useful in low-renin (salt-sensitive) states, for example older people, and black or obese patients. Resistant hypertension (see below), common in these groups, is frequently due to inadequate diuretic therapy. Despite half a century of use, disagreement continues about their optimum dosing and whether blood pressure lowering effects and cardiovascular benefits are common to all agents in the class. There is continuing controversy about their potential metabolic disadvantages – concern about these, together with their low pharmaceutical profile, prevents their being used in many patients – but there is no evidence that these in any way blunt their cardiovascular benefits, even in people with diabetes (Box 11.7). They are as effective in reducing coronary events as any other class of antihypertensive agents, but in ALLHAT were more effective in reducing heart failure and stroke than lisinopril or amlodipine...

Read More »